172 related articles for article (PubMed ID: 24676404)
21. N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection.
Li Y; Rey-Cuille MA; Hu SL
AIDS Res Hum Retroviruses; 2001 Nov; 17(16):1473-9. PubMed ID: 11709091
[TBL] [Abstract][Full Text] [Related]
22. Unique profile of predominant CCR5-tropic in CRF07_BC HIV-1 infections and discovery of an unusual CXCR4-tropic strain.
Hu X; Feng Y; Li K; Yu Y; Rashid A; Xing H; Ruan Y; Lu L; Wei M; Shao Y
Front Immunol; 2022; 13():911806. PubMed ID: 36211390
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07_BC strains circulating in the Xinjiang Province of China.
Ma L; Guo Y; Yuan L; Huang Y; Sun J; Qu S; Yu X; Meng Z; He X; Jiang S; Shao Y
Retrovirology; 2009 May; 6():45. PubMed ID: 19442296
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies.
Singh A; Collman RG
J Virol; 2000 Nov; 74(21):10229-35. PubMed ID: 11024154
[TBL] [Abstract][Full Text] [Related]
25. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
Huang W; Eshleman SH; Toma J; Fransen S; Stawiski E; Paxinos EE; Whitcomb JM; Young AM; Donnell D; Mmiro F; Musoke P; Guay LA; Jackson JB; Parkin NT; Petropoulos CJ
J Virol; 2007 Aug; 81(15):7885-93. PubMed ID: 17507467
[TBL] [Abstract][Full Text] [Related]
26. Predicted co-receptor tropism and sequence characteristics of China HIV-1 V3 loops: implications for the future usage of CCR5 antagonists and AIDS vaccine development.
Zhang C; Xu S; Wei J; Guo H
Int J Infect Dis; 2009 Sep; 13(5):e212-6. PubMed ID: 19217335
[TBL] [Abstract][Full Text] [Related]
27. Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.
Fernàndez G; Llano A; Esgleas M; Clotet B; Esté JA; Martínez MA
J Gen Virol; 2006 May; 87(Pt 5):1285-1294. PubMed ID: 16603531
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for coreceptor selectivity by the HIV type 1 V3 loop.
Cardozo T; Kimura T; Philpott S; Weiser B; Burger H; Zolla-Pazner S
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):415-26. PubMed ID: 17411375
[TBL] [Abstract][Full Text] [Related]
29. A virus-envelope paired competitive assay to study entry efficiency of human immunodeficiency virus type 1 in vitro.
Schwalbe B; Hauser H; Schreiber M
J Virol Methods; 2014 Sep; 205():91-8. PubMed ID: 24859049
[TBL] [Abstract][Full Text] [Related]
30. Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.
Lin NH; Becerril C; Giguel F; Novitsky V; Moyo S; Makhema J; Essex M; Lockman S; Kuritzkes DR; Sagar M
Virology; 2012 Nov; 433(2):296-307. PubMed ID: 22954962
[TBL] [Abstract][Full Text] [Related]
31. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
[TBL] [Abstract][Full Text] [Related]
32. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
[TBL] [Abstract][Full Text] [Related]
33. Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop.
Sato H; Kato K; Takebe Y
Virology; 1999 May; 257(2):491-501. PubMed ID: 10329559
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.
Pollakis G; Abebe A; Kliphuis A; Chalaby MI; Bakker M; Mengistu Y; Brouwer M; Goudsmit J; Schuitemaker H; Paxton WA
J Virol; 2004 Mar; 78(6):2841-52. PubMed ID: 14990703
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2.
Xiang SH; Pacheco B; Bowder D; Yuan W; Sodroski J
Virology; 2013 Mar; 438(1):5-13. PubMed ID: 23369572
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
[TBL] [Abstract][Full Text] [Related]
37. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
Labrosse B; Treboute C; Brelot A; Alizon M
J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
[TBL] [Abstract][Full Text] [Related]
38. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
39. Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4.
Esté JA; Cabrera C; Blanco J; Gutierrez A; Bridger G; Henson G; Clotet B; Schols D; De Clercq E
J Virol; 1999 Jul; 73(7):5577-85. PubMed ID: 10364306
[TBL] [Abstract][Full Text] [Related]
40. Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.
Schwalbe B; Schreiber M
PLoS One; 2015; 10(3):e0119879. PubMed ID: 25785610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
